Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

Condition:   Severe Eosinophilic Asthma Intervention:   Sponsor:   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials